Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Eric Frings

Mr. Frings joined Dynavax in 2011 and currently serves as Vice President, Site Head and Managing Director for Dynavax GmbH, where the drug substance for HEPLISAV-B is manufactured, in Duesseldorf, Germany.

Overview Structured Data Issues Contributors Activity

Is a

Person

No article content yet.

Timeline

No Timeline data yet.

Current Employer

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more people like Eric Frings

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.